Skip to main content

Table 2 Adverse Reactions Categorized by Severity and Agent

From: 2015 Update on Acute Adverse Reactions to Gadolinium based Contrast Agents in Cardiovascular MR. Large Multi-National and Multi-Ethnical Population Experience With 37788 Patients From the EuroCMR Registry

Agent N° of Examinations N° of Adverse Reactions
Mild Moderate Severe Total
Gadopentetat (e.g. Magnevist) 12810 18 (0.14) 0 2 (0.02) 20 (0.16)
Gadoteracid (e.g. Dotarem) 4235 5 (0.12) 0 0 5 (0.12)
Gadobenat (e.g. Multihance) 706 3 (0.42) 0 0 3 (0.42)
Gadobutrol (e.g. Gadovist) 9378 9 (0.1) 0 0 9 (0.10)
Gadoteridol (e.g. Prohance) 1045 2 (0.19) 0 0 2 (0.19)
Gadodiamide (e.g. Omniscan) 6116 3 (0.05) 0 0 3 (0.05)
Other 3498 3 (0.09) 0 0 3 (0.09)
Total 37788 43 (0.11) 0 2 (0.01) 45 (0.12)
  1. Note - Values in parentheses are percentages